- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Viruses 2014, 6, 2122-2137; doi:10.3390/v6052122
- Klassifikation
-
Landwirtschaft, Veterinärmedizin
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2015
- Urheber
-
Gentschev, Ivaylo
Patil, Sadeep S.
Petrov, Ivan
Cappello, Joseph
Adelfinger, Marion
Szalay, Aladar A.
- URN
-
urn:nbn:de:bvb:20-opus-119753
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gentschev, Ivaylo
- Patil, Sadeep S.
- Petrov, Ivan
- Cappello, Joseph
- Adelfinger, Marion
- Szalay, Aladar A.
- Universität Würzburg
Entstanden
- 2015
Ähnliche Objekte (12)
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
“Il n’y a pas de chats”: Feline Absence and/as the Space of Zoopoetics
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
“Il n’y a pas de chats”: Feline Absence and/as the Space of Zoopoetics
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients
Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy
Canine Adipose-Derived Mesenchymal Stem Cells (cAdMSCs) as a "Trojan Horse" in Vaccinia Virus Mediated Oncolytic Therapy against Canine Soft Tissue Sarcomas
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Evaluation of a New Recombinant Oncolytic Vaccinia Virus Strain GLV-5b451 for Feline Mammary Carcinoma Therapy
“Il n’y a pas de chats”: Feline Absence and/as the Space of Zoopoetics
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy